The "U.S. Small Molecule Innovator API CDMO Market Size, Share & Trends Analysis Report by Stage Type (Preclinical, Clinical, Commercial), Customer Type, Therapeutic Area, Region, and Segment ...
Small molecule drugs dominate new drug approvals and are crucial for treating diverse diseases. They are typically low-weight, providing easy absorption and versatile delivery methods. Their simpler ...
Dublin, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The "Small Molecule Innovator CDMO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...
TEL AVIV, Israel--(BUSINESS WIRE)--Teva announced today its intention to divest its active-pharmaceutical ingredient (API) business, or "TAPI". TAPI is a global leader in the small-molecule API ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results